Literature DB >> 27928758

Mapping CHU9D Utility Scores from the PedsQLTM 4.0 SF-15.

Christine Mpundu-Kaambwa1, Gang Chen2, Remo Russo3,4, Katherine Stevens5, Karin Dam Petersen6, Julie Ratcliffe7.   

Abstract

BACKGROUND: The Pediatric Quality of Life Inventory™ 4.0 Short Form 15 Generic Core Scales (hereafter the PedsQL) and the Child Health Utility-9 Dimensions (CHU9D) are two generic instruments designed to measure health-related quality of life in children and adolescents in the general population and paediatric patient groups living with specific health conditions. Although the PedsQL is widely used among paediatric patient populations, presently it is not possible to directly use the scores from the instrument to calculate quality-adjusted life-years (QALYs) for application in economic evaluation because it produces summary scores which are not preference-based.
OBJECTIVE: This paper examines different econometric mapping techniques for estimating CHU9D utility scores from the PedsQL for the purpose of calculating QALYs for cost-utility analysis.
METHODS: The PedsQL and the CHU9D were completed by a community sample of 755 Australian adolescents aged 15-17 years. Seven regression models were estimated: ordinary least squares estimator, generalised linear model, robust MM estimator, multivariate factorial polynomial estimator, beta-binomial estimator, finite mixture model and multinomial logistic model. The mean absolute error (MAE) and the mean squared error (MSE) were used to assess predictive ability of the models.
RESULTS: The MM estimator with stepwise-selected PedsQL dimension scores as explanatory variables had the best predictive accuracy using MAE and the equivalent beta-binomial model had the best predictive accuracy using MSE.
CONCLUSIONS: Our mapping algorithm facilitates the estimation of health-state utilities for use within economic evaluations where only PedsQL data is available and is suitable for use in community-based adolescents aged 15-17 years. Applicability of the algorithm in younger populations should be assessed in further research.

Entities:  

Mesh:

Year:  2017        PMID: 27928758     DOI: 10.1007/s40273-016-0476-y

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  41 in total

1.  Estimating log models: to transform or not to transform?

Authors:  W G Manning; J Mullahy
Journal:  J Health Econ       Date:  2001-07       Impact factor: 3.883

2.  Mapping the Oxford hip score onto the EQ-5D utility index.

Authors:  Rafael A Pinedo-Villanueva; David Turner; Andrew Judge; James P Raftery; Nigel K Arden
Journal:  Qual Life Res       Date:  2012-04-22       Impact factor: 4.147

3.  Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis.

Authors:  M Boers; A C Verhoeven; H M Markusse; M A van de Laar; R Westhovens; J C van Denderen; D van Zeben; B A Dijkmans; A J Peeters; P Jacobs; H R van den Brink; H J Schouten; D M van der Heijde; A Boonen; S van der Linden
Journal:  Lancet       Date:  1997-08-02       Impact factor: 79.321

4.  An assessment of the construct validity of the CHU9D in the Australian adolescent general population.

Authors:  Julie Ratcliffe; Katherine Stevens; Terry Flynn; John Brazier; Michael Sawyer
Journal:  Qual Life Res       Date:  2011-08-12       Impact factor: 4.147

5.  Mapping to obtain EQ-5D utility values for use in NICE health technology assessments.

Authors:  Louise Longworth; Donna Rowen
Journal:  Value Health       Date:  2013 Jan-Feb       Impact factor: 5.725

6.  Model selection in competing risks regression.

Authors:  Deborah Kuk; Ravi Varadhan
Journal:  Stat Med       Date:  2013-02-24       Impact factor: 2.373

7.  Developing adolescent-specific health state values for economic evaluation: an application of profile case best-worst scaling to the Child Health Utility 9D.

Authors:  Julie Ratcliffe; Terry Flynn; Frances Terlich; Katherine Stevens; John Brazier; Michael Sawyer
Journal:  Pharmacoeconomics       Date:  2012-08-01       Impact factor: 4.981

8.  Measuring and valuing health benefits for economic evaluation in adolescence: an assessment of the practicality and validity of the child health utility 9D in the Australian adolescent population.

Authors:  Katherine Stevens; Julie Ratcliffe
Journal:  Value Health       Date:  2012-10-25       Impact factor: 5.725

9.  Mapping oral health related quality of life to generic health state values.

Authors:  David S Brennan; A John Spencer
Journal:  BMC Health Serv Res       Date:  2006-08-07       Impact factor: 2.655

Review 10.  Review of studies mapping from quality of life or clinical measures to EQ-5D: an online database.

Authors:  Helen Dakin
Journal:  Health Qual Life Outcomes       Date:  2013-09-05       Impact factor: 3.186

View more
  9 in total

1.  Measuring Health-Related Quality of Life in Adolescent Populations: An Empirical Comparison of the CHU9D and the PedsQLTM 4.0 Short Form 15.

Authors:  Karin Dam Petersen; Gang Chen; Christine Mpundu-Kaambwa; Katherine Stevens; John Brazier; Julie Ratcliffe
Journal:  Patient       Date:  2018-02       Impact factor: 3.883

2.  Using Animation to Self-Report Health: A Randomized Experiment with Children.

Authors:  Carla Guerriero; Neus Abrines Jaume; Karla Diaz-Ordaz; Katherine Loraine Brown; Jo Wray; Joan Ashworth; Matt Abbiss; John Cairns
Journal:  Patient       Date:  2020-04       Impact factor: 3.883

3.  Mapping the Shah-modified Barthel Index to the Health Utility Index Mark III by the Mean Rank Method.

Authors:  Yin Bun Cheung; Hui Xing Tan; Nan Luo; Hwee Lin Wee; Gerald C H Koh
Journal:  Qual Life Res       Date:  2019-07-27       Impact factor: 4.147

4.  Mapping the PedsQL™ onto the CHU9D: An Assessment of External Validity in a Large Community-Based Sample.

Authors:  Christine Mpundu-Kaambwa; Gang Chen; Elisabeth Huynh; Remo Russo; Julie Ratcliffe
Journal:  Pharmacoeconomics       Date:  2019-09       Impact factor: 4.981

5.  Mapping the Paediatric Quality of Life Inventory (PedsQL™) Generic Core Scales onto the Child Health Utility Index-9 Dimension (CHU-9D) Score for Economic Evaluation in Children.

Authors:  Tosin Lambe; Emma Frew; Natalie J Ives; Rebecca L Woolley; Carole Cummins; Elizabeth A Brettell; Emma N Barsoum; Nicholas J A Webb
Journal:  Pharmacoeconomics       Date:  2018-04       Impact factor: 4.981

6.  Mapping PedsQLTM scores onto CHU9D utility scores: estimation, validation and a comparison of alternative instrument versions.

Authors:  Rohan Sweeney; Gang Chen; Lisa Gold; Fiona Mensah; Melissa Wake
Journal:  Qual Life Res       Date:  2019-11-19       Impact factor: 4.147

7.  An Assessment of the Validity and Reliability of the Pediatric Child Health Utility 9D in Children with Inflammatory Bowel Disease.

Authors:  Naazish S Bashir; Thomas D Walters; Anne M Griffiths; Wendy J Ungar
Journal:  Children (Basel)       Date:  2021-04-27

8.  Preimplantation genetic diagnosis for retinoblastoma survivors: a cost-effectiveness study.

Authors:  D Schofield; M J B Zeppel; S Staffieri; R N Shrestha; D Jelovic; E Lee; R V Jamieson
Journal:  Reprod Biomed Soc Online       Date:  2020-05-11

9.  Deriving health utility indices from a food allergy quality-of-life questionnaire.

Authors:  Gang Chen; Audrey DunnGalvin; Matthew Greenhawt; Marcus Shaker; Dianne E Campbell
Journal:  Pediatr Allergy Immunol       Date:  2021-08-06       Impact factor: 5.464

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.